|
1
|
Fukushima K, Tsuchiya K, Kano Y, Horita N,
Hibiya S, Hayashi R, Kitagaki K, Negi M, Itoh E, Akashi T, et al:
Atonal homolog 1 protein stabilized by tumor necrosis factor α
induces high malignant potential in colon cancer cell line. Cancer
Sci. 106:1000–1007. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
International Agency for Research on
Cancer: Estimated incidence, mortality and 5-year prevalence. Both
sexes [EB/OL]. http://globocan.iarc.fr/Pages/fact_sheets_population.aspx2017
|
|
3
|
National cancer institute: SEER stat fact
sheets. Colon and rectum cancer [EB/OL]. http://seer.cancer.gov/statfacts/html/colorect.html2017.
|
|
4
|
Andersen HS, Bertelsen CA, Henriksen R,
Campos AH, Kristensen B, Ingeholm P and Gögenur I: The pathological
phenotype of colon cancer with microsatellite instability. Dan Med
J. 63(pii): A51982016.PubMed/NCBI
|
|
5
|
van de Velde CJ, Aristei C, Boelens PG,
Beets-Tan RG, Blomqvist L, Borras JM, van den Broek CB, Brown G,
Coebergh JW, Cutsem EV, et al; EURECCA colorectal, .
Multidisciplinary mission statement on better care for patients
with colon and rectal cancer in Europe. Eur J Cancer. 49:2784–2790.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ku G, Tan IB, Yau T, Boku N, Laohavinij S,
Cheng AL, Kang YK and de Lima Lopes G Jr: Management of colon
cancer: Resource-stratified guidelines from the Asian oncology
summit 2012. Lancet Oncol. 13:e470–e481. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Guan X, Chen W, Liu Z, Jiang Z, Hu H, Zhao
Z, Wang S, Chen Y, Wang G and Wang X: Whether regional lymph nodes
evaluation should be equally required for both right and left colon
cancer. Oncotarget. 7:59945–59956. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Huang B, Feng Y, Zhu L, Xu T, Huang L and
Cai G: Smaller tumor size is associated with poor survival in stage
II colon cancer: An analysis of 7,719 patients in the SEER
database. Int J Surg. 33:Pt A. 157–163. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bogachev O, Majdalawieh A, Pan X, Zhang L
and Ro HS: Adipocyte enhancer-binding protein 1 (AEBP1) (a novel
macrophage proinflammatory mediator) overexpression promotes and
ablation attenuates atherosclerosis in ApoE (−/-) and LDLR (−/-)
mice. Mol Med. 17:1056–1064. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Majdalawieh A and Ro HS: Regulation of
IkappaBalpha function and NF-kappaB signaling: AEBP1 is a novel
proinflammatory mediator in macrophages. Mediators Inflamm.
2010:8238212010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hu W, Jin L, Jiang CC, Long GV, Scolyer
RA, Wu Q, Zhang XD, Mei Y and Wu M: AEBP1 upregulation confers
acquired resistance to BRAF (V600E) inhibition in melanoma. Cell
Death Dis. 4:e9142013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ladha J, Sinha S, Bhat V, Donakonda S and
Rao SM: Identification of genomic targets of transcription factor
AEBP1 and its role in survival of glioma cells. Mol Cancer Res.
10:1039–1051. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hu H, Krasinskas A and Willis J:
Perspectives on current tumor-node-metastasis (TNM) staging of
cancers of the colon and rectum. Semin Oncol. 38:500–510. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bradford MM: A rapid and sensitive method
for the quantitation of microgram quantities of protein utilizing
the principle of protein-dye binding. Anal Biochem. 72:248–254.
1976. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li B, Chen P, Chang Y, Qi J, Fu H and Guo
H: Let-7a inhibits tumor cell growth and metastasis by directly
targeting RTKN in human colon cancer. Biochem Biophys Res Commun.
478:739–745. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Majdalawieh A and Ro HS: PPARgamma1 and
LXRalpha face a new regulator of macrophage cholesterol homeostasis
and inflammatory responsiveness, AEBP1. Nucl Recept Signal.
8:e0042010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Holloway RW, Bogachev O, Bharadwaj AG,
McCluskey GD, Majdalawieh AF, Zhang L and Ro HS: Stromal adipocyte
enhancer-binding protein (AEBP1) promotes mammary epithelial cell
hyperplasia via proinflammatory and hedgehog signaling. J Biol
Chem. 287:39171–39181. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yamashita S, Takahashi S, McDonell N,
Watanabe N, Niwa T, Hosoya K, Tsujino Y, Shirai T and Ushijima T:
Methylation silencing of transforming growth factor-beta receptor
type II in rat prostate cancers. Cancer Res. 68:2112–2121. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sumpio C, Knobf MT and Jeon S: Treatment
complexity: A description of chemotherapy and supportive care
treatment visits in patients with advanced-stage cancer diagnoses.
Support Care Cancer. 24:285–293. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Young JI, Mongoue-Tchokote S, Wieghard N,
Mori M, Vaccaro GM, Sheppard BC and Tsikitis VL: Treatment and
survival of small-bowel adenocarcinoma in the United States: A
comparison with colon cancer. Dis Colon Rectum. 59:306–315. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Muthalagu N, Junttila MR, Wiese KE, Wolf
E, Morton J, Bauer B, Evan GI, Eilers M and Murphy DJ: BIM is the
primary mediator of MYC-induced apoptosis in multiple solid
tissues. Cell Rep. 8:1347–1353. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fang Y, Shen H, Li H, Cao Y, Qin R, Long
L, Zhu X, Xie C and Xu W: miR-106a confers cisplatin resistance by
regulating PTEN/Akt pathway in gastric cancer cells. Acta Biochim
Biophys Sin (Shanghai). 45:963–972. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Valeri N, Gasparini P, Braconi C, Paone A,
Lovat F, Fabbri M, Sumani KM, Alder H, Amadori D, Patel T, et al:
MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating
human DNA MutS homolog 2 (hMSH2). Proc Natl Acad Sci USA.
107:21098–21103. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mishra PJ, Humeniuk R, Mishra PJ,
Longo-Sorbello GS, Banerjee D and Bertino JR: A miR-24 microRNA
binding-site polymorphism in dihydrofolate reductase gene leads to
methotrexate resistance. Proc Natl Acad Sci USA. 104:13513–13518.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Qiang R, Wang F, Shi LY, Liu M, Chen S,
Wan HY, Li YX, Li X, Gao SY, Sun BC and Tang H: Plexin-B1 is a
target of miR-214 in cervical cancer and promotes the growth and
invasion of HeLa cells. Int J Biochem Cell Biol. 43:632–641. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang Z, Chen S, Luan X, Li Y, Liu M, Li X,
Liu T and Tang H: MicroRNA-214 is aberrantly expressed in cervical
cancers and inhibits the growth of HeLa cells. IUBMB Life.
61:1075–1082. 2009. View
Article : Google Scholar : PubMed/NCBI
|
